prednisone has been researched along with Child Development Deviations in 6 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Infants diagnosed with acute lymphoblastic leukemia (ALL) are considered the patient subgroup at the highest risk for central nervous system (CNS) disease, both at presentation and as an isolated extramedullary relapse." | 1.30 | Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report. ( Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK, 1999) |
| "When a neuroblastoma was present, tumor removal did not improve symptoms." | 1.29 | Outcome of children with opsoclonus-myoclonus regardless of etiology. ( Hammer, MS; Larsen, MB; Stack, CV, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| EERLAND, MF | 1 |
| KNOL, K | 1 |
| Hollister, JR | 1 |
| Hammer, MS | 1 |
| Larsen, MB | 1 |
| Stack, CV | 1 |
| Kaleita, TA | 1 |
| Reaman, GH | 1 |
| MacLean, WE | 1 |
| Sather, HN | 1 |
| Whitt, JK | 1 |
| Glaze, DG | 1 |
| Hrachovy, RA | 1 |
| Frost, JD | 1 |
| Kellaway, P | 1 |
| Zion, TE | 1 |
| Bobrow, M | 1 |
| Emerson, PM | 1 |
| Spriggs, AI | 1 |
| Ellis, HL | 1 |
6 other studies available for prednisone and Child Development Deviations
| Article | Year |
|---|---|
GROWTH RETARDATION IN ASTHMATIC CHILDREN RECEIVING PREDNISONE FOR A LONG PERIOD.
Topics: Asthma; Body Height; Child; Developmental Disabilities; Humans; Pharmacology; Prednisone | 1964 |
Delay in motor development as a presentation of juvenile rheumatoid arthritis.
Topics: Arthritis, Juvenile; Developmental Disabilities; Humans; Infant; Male; Motor Skills; Prednisone | 1981 |
Outcome of children with opsoclonus-myoclonus regardless of etiology.
Topics: Adrenocorticotropic Hormone; Child, Preschool; Developmental Disabilities; Epilepsies, Myoclonic; Fe | 1995 |
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disor | 1999 |
Prospective study of outcome of infants with infantile spasms treated during controlled studies of ACTH and prednisone.
Topics: Adrenocorticotropic Hormone; Child, Preschool; Developmental Disabilities; Electroencephalography; H | 1988 |
Ring-1 chromosome, microcephalic dwarfism, and acute myeloid leukemia.
Topics: Anemia, Hemolytic; Anemia, Hypochromic; Birth Weight; Blood Cell Count; Bone Marrow Examination; Chi | 1973 |